Stephan Engels – The Milli Chronicle

Tuesday, October 21, 2025

Latest:

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle October 21, 2025October 21, 2025 biotech innovation, board of directors., board reshuffle, Britt Meelby Jensen, Cees de Jong, corporate governance, Danish pharma, global leadership, Helena Saxon, Helge Lund, Kasim Kutay, Lars Rebien Sørensen, Mikael Dolsten, Novo Holdings, Novo Nordisk, Novo Nordisk Foundation, Ozempic, pharmaceutical industry, Stephan Engels, sustainable growth, Wegovy

Novo Nordisk’s New Power Lineup: A Fresh Era of Leadership and Strategy

Novo Nordisk ushers in a new leadership team blending deep industry experience, scientific excellence, and strategic vision. In a move